David M Neville

USPTO Granted Patents = 22 (Patent Applications = 4)

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 374(Granted Patents)

Company Filing History:

11 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

7 out of 1,215

The United States of America As Represented by the Department of Health

The Uab Research Foundation

patents

5. 1 out of 2,202

The United States of America As Represented by the Secretary of

Scott & White Healthcare

patents

8. 1 out of 4,119

Wisconsin Alumni Research Foundation

patents

9. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1982-2021

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11098120 - Immunomodulation by anti-CD3 immunotoxins to treat cancers bearing or not uniformly bearing surface CD3 (2021-08-24),

2. 9364557 - Fold-back diabody diphtheria toxin immunotoxin and methods of use (2016-06-14),

3. 8987426 - Immunotoxin fusion proteins and means for expression thereof (2015-03-24),

4. 8921097 - Methods for expression and purification of immunotoxins (2014-12-30),

5. 8217158 - Immunotoxin fusion proteins and means for expression thereof (2012-07-10),

6. 7892786 - Methods for expression and purification of immunotoxins (2011-02-22),

7. 7696338 - Immunotoxin fusion proteins and means for expression thereof (2010-04-13),

8. 7517527 - Immunotoxin with in vivo T cell suppressant activity and methods of use (2009-04-14),

9. 7288254 - Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation (2007-10-30),

10. 7125553 - Methods of inducing immune tolerance using immunotoxins (2006-10-24),

11. 6632928 - Immunotoxins and methods of inducing immune tolerance (2003-10-14),

12. 6103235 - Methods of inducing immune tolerance using immunotoxins (2000-08-15),

13. 5762927 - Thymus tolerance in primates (1998-06-09),

14. 5725857 - Immunotoxin with in vivo T cell suppressant activity and methods of use (1998-03-10),

15. 5167956 - Immunotoxin with in-vivo T cell suppressant activity (1992-12-01),

Title: The Innovative Journey of David M Neville

Introduction:

David M Neville, a distinguished inventor hailing from Bethesda, MD, has made significant contributions to the field of technology and innovation through his groundbreaking inventions and patents.

Latest Patents:

David M Neville's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights:

With over two decades of experience in the industry, David M Neville has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible. His innovative spirit has led to the creation of several patented technologies that have revolutionized their respective industries.

Collaborations:

Throughout his career, David M Neville has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects, highlighting his strong communication and leadership skills.

Conclusion:

In conclusion, David M Neville's passion for innovation, coupled with his technical expertise and collaborative approach, has cemented his reputation as a trailblazer in the world of inventions. His relentless pursuit of excellence continues to inspire the next generation of inventors and solidify his legacy in the realm of technological advancements.

This text is generated by artificial intelligence and may not be accurate.